Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > PRC partners analysis
View:
Post by noclue80 on Jun 27, 2022 7:21am

PRC partners analysis

"Since the AbbVie deal was announced, Sirona Biochem has been approached by several major institutions, funds and investment banking firms. Initial meetings have already taken place and will be followed up by high-profile meetings all over the world in the coming weeks. As far as we know, additional meetings will take place in Germany, France, the U.S and Canada."

"In a recent conversation with the current CEO, Dr. Howard Verrico, we were made aware that the company has already begun the process of looking for a suitable CEO, either one from Europe or a multi-lingual candidate, to take the company to the next level. Dr. Verrico would remain with the company as president and chairman of the board. "

"The animal health market may not be as large as the anti-aging market, but a deal with a top animal pharmaceutical company could still translate to tens of millions of dollars in royalty payments."

57ea05_4dfabf8ca3aa4f9e929d16bcfcc954dd.pdf (usrfiles.com)
Comment by navajojoe on Jun 27, 2022 8:39am
This post has been removed in accordance with Community Policy
Comment by Pareto8020 on Jun 27, 2022 8:46am
Sounds like they definitely have access to more details than the average joe on the street that is for sure. Maybe that is why they are comfortable making a 10 bag prediction- they know what the Allergan #'s look like - and the look darn good. Surprised the # of meetings with institutions, etc they have lined up already.  I guess they all see an angle to fill their coffers with SBM ...more  
Comment by navajojoe on Jun 27, 2022 9:25am
This post has been removed in accordance with Community Policy
Comment by Pareto8020 on Jun 27, 2022 10:46am
Hopefully the new CEO has a little more savvy running a company and desiminating info than the current one. The appointment of a new CEO - if it is the right one- could be a real boost to Sirona and it's share price.
Comment by MirrorWorldMan on Jun 27, 2022 12:53pm
New CEO is the perfect choice, as long as Howie doesn't fire him for creating insights thay Howie doesn't like. I would remove Howie from position of authority and keep him as a board member only, but he is too vane for that
Comment by Engcan77 on Jun 27, 2022 1:07pm
Agree Mirror. He just can't let go. Always wants the last say. He has to hire an appropriate CEO to take us to the next level, and let him or her run with it. If not, then we will end up with the same result as the last 2 CEO's.   Like someone else said...we need a strong CEO that will stand up to Howard, and not just be his 'whipping boy'. Please Howard...back off, and ...more  
Comment by Engcan77 on Jun 27, 2022 10:49am
Navajoejoe. I previouly made a comment about my concerns about 'some' having insite into Sirona's dealings,while others that are kept in the dark. My concerns were not only of the numbers.but other info. Giving info to shareholders at a later date is still wrong. My comment: So, we have certain individuals that can buy and sell Sirona shares, that have the insight to the numbers from ...more  
Comment by Engcan77 on Jun 27, 2022 10:58am
I would assume that PRC partners does not have the info on the numbers on the new deal, however seem to get alot of info ahead of us investors. I believe it is info that could have an affect on the share price. I guess Sirona has to believe the info they are giving PRC partners ahead of time, would not have an affect on the share price. Unless the person giving this info, has no idea how a public ...more  
Comment by lscfa on Jun 27, 2022 10:54am
PRC can't even get it right.  After the clinical study was public Sirona moved away from the phrase skin lightening and only talks about dark spots.      quote=navajojoe] The problem is, PRC is apparently a shareholder, and yet has info we don't? That is not acceptable.[/quote]
Comment by Pareto8020 on Jun 27, 2022 11:02am
Howard seems to be using PRC as more of a promo company than anything.  Why are they paying CURE then?  Goes to a long list of zigs when they should have been zagging. Said it before - a CEO shouldn't be a learn as you go position.  Been too many obvious mistakes, wrong turns and plain old fashioned mismanagement at the shareholders expense.  
Comment by Engcan77 on Jun 27, 2022 11:02am
'Skin lightening' is now wording that not looked at in a good way.
Comment by lscfa on Jun 27, 2022 11:05am
Results TFC-1067 and 2% hydroquinone produced statistically significant skin lightening after 8 weeks of use, but only hydroquinone lightened the normal skin. This pattern continued into week 12 where both products significantly lightened dyschromic skin, but hydroquinone also lightened the normal skin, which is not always desirable.
Comment by navajojoe on Jun 27, 2022 2:18pm
This post has been removed in accordance with Community Policy
Comment by MirrorWorldMan on Jun 27, 2022 11:09am
Insti's will require a placement and can manipulate a stock greatly in corrosive ways.   Now we know where Howie is going to get his money to pay for all those things he is planning. He is absolutely out of his wheelhouse in dealing with the smaller and medium sized Funds etc and needs shrewed experienced people that recognize potential dangers. Issues are very real. Some in investment ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities